ECMO（体外式膜型人工肺）の世界市場-2022-2029年

市場力学

肺がんの有病率上昇、老年人口の増加、ECMO技術の向上が、ECMO（体外式膜型人工肺）の世界市場を牽引する主な要因となっています。

肺がんの有病率の上昇と老年人口の増加が市場成長の原動力になると予想されます。

体外式膜酸素供給装置市場は、肺がんの有病率の上昇、老年人口の増加、ECMO技術の改善など、さまざまな要因がECMO装置市場の他の推進力になると予想されます。

また、ECMOセンター、会議、技術に関する認識を高めるためのトレーニングプログラムの数が増加していることも、市場の成長の要因として挙げられます。さらに、主要企業による技術的に高度な装置の利用可能性も、市場の成長に重要な役割を果たすと予想されます。

WHOによると、慢性閉塞性肺疾患（COPD）は、世界で約2億人が罹患しているとされています。現在、慢性疾患の治療に対する政府組織による資金調達が増加しており、市場の成長を後押しするものと思われます。

例えば、欧州連合では、COPDの直接費用は、総医療費の約6％であり、呼吸器疾患の総費用のほぼ56％を占めています。また、体外式膜酸素化市場の促進要因として、肺移植のためのECMO技術の採用率が高いことが挙げられます。このように、患者や病院における体外式膜酸素化技術に関する認知度の向上は、市場参加者に将来的により良い機会を提供することになります。

一部のECMO（体外式膜型人工肺）に関連する副作用と高コストが市場成長の妨げになると予想されます。

これらの機械やこれらの治療法のコストが高いことが、市場を抑制する主な要因となっています。この治療法は、多くの時間を要し、多くの医療専門家が患者の観察およびケアのためにチームを組むため、徐々にコストが上昇します。

産業分析

体外式膜酸素供給装置の世界市場は、ポーターのファイブフォース、規制分析、サプライチェーン分析、価格分析、アンメットニーズ、製品イノベーションなどの様々な産業要因に基づいて、市場の詳細な分析を提供します。

ECMO（体外式膜型人工肺）の世界市場レポートでは、約45+の市場データ表、40+の図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

• 市場影響要因
  • 促進要因
    • 肺がんの有病率上昇と老年人口の増加
  • Restraints（制約要因
    • 一部のECMO（体外式膜型人工肺）による高コストと副作用
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• 規制分析
• サプライチェーン分析
• プライシング分析
• アンメットニーズ
• 製品イノベーション

第6章 モダリティタイプ別

• 静脈動脈（VA）
• 静脈瘤（VV）
• 動脈-静脈（AV）

第7章 アプリケーション別

• 呼吸器系
• 心臓
• 体外式心肺蘇生法（ECPR）

第8章 コンポーネント別

• ポンプ類
• 酸素供給器
• コントローラー
• カニューレ
• アクセサリー

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第10章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク
• 注目の主要企業リスト

第11章 企業プロファイル

• Medtronic plc.
• MAQUET Holding B. V. & Co. KG
• LivaNova PLC
• XENIOS AG
• Terumo Corporation
• MicroPort Scientific Corporation
• NIPRO Corporation
• OriGen Biomedical Inc
• ALung Technologies Inc
• EUROSETS S.r.l.

第12章 ECMO（体外式膜型人工肺）の世界市場-DataM

Market Overview

Extracorporeal Membrane Oxygenation Machine Market size was valued US$ 553 million in 2022 and is estimated to reach US$ 708 million by 2029, growing at a CAGR of 5.1% during the forecast period (2022-2029).

An extracorporeal membrane oxygenation machine also known as a life support machine is used in the treatment of various heart and lung diseases. The main purpose of an extracorporeal membrane oxygenation machine is to provide enough oxygen to the body when the heart and lungs are not functioning properly. This machine is used worldwide for the treatment of lung cancer and chronic disorders.

Market Dynamics

Rising prevalence rates of lung cancer, increasing geriatric population, improvements in ECMO technology are the major factors driving the global extracorporeal membrane oxygenation machine market.

The increasing prevalence rates of lung cancer and increasing geriatric population are expected to drive the growth of market.

The extracorporeal membrane oxygenation machine market is driven by various factors such as rising prevalence rates of lung cancer, increasing geriatric population, improvements in ECMO technology are expected to be other driving forces for the ECMO machine market.

The growth of the market can also be attributed to the rising number of ECMO centres, conferences, and training programs to increase awareness about the technology. Moreover, the availability of technologically advanced devices by key players is also expected to play a vital role in the growth of the market.

According to the WHO, chronic obstructive pulmonary disease (COPD) affects nearly 200 million people globally. Today, rising funding by government organizations for the treatment of chronic diseases will boost market growth.

For instance, in European Union the direct cost of COPD is around 6% of total health expenditure, accounting for nearly 56% of the total cost of respiratory diseases. Another, driving factor for the extracorporeal membrane oxygenation market is the high adoption rate of ECMO techniques for lung transplantation. Thus, increasing awareness about extracorporeal membrane oxygenation techniques among the patients and in hospitals will provide market players with better opportunities in the future.

Adverse effects associated with some extracorporeal membrane oxygenation machine and high cost are expected to hamper the market growth.

The high cost of these machines and these therapies are the main factors responsible for the restraining of the market. This therapy takes a lot of time and many medical professionals team for observation and care of patient during the procedure this gradually increases the cost.

Industry Analysis

The global extracorporeal membrane oxygenation machine market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis, Unmet Needs, Product Innovations.

Segment Analysis

Application segment is expected to hold the largest market share in global Extracorporeal Membrane Oxygenation Machine market

Based on Modality, the global Extracorporeal Membrane Oxygenation Machine market is segmented into Veno-arterial (VA), Veno-venous (VV), and Arterio-venous (AV). These modalities are used to provide hemodynamic support and to facilitate gaseous exchange in patients with cardiac or respiratory failure.

Among these, Veno-venous (VV) segment is expected to account for the largest share of the market in 2019. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, and technological advancements.

According to the U.S. National Institute of Health (NIH), a combination of veno-venous and veno-arterial is used in specific cases, such as cardiogenic shock. The veno-arterial segment led the market in 2019.

Veno-arterial systems can be used for the treatment/management of decreased cardiac output and tissue hypoperfusion, which results in cardiogenic shock. This can act as a trigger for a myocardial infarction or chronic ischemia.

Based on Application, the global Extracorporeal Membrane Oxygenation Machine market is segmented into Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the Increasing number of people suffering from chronic diseases such as obesity and diabetes, highly susceptible to suffer from cardiovascular conditions will drive the extracorporeal cardiopulmonary resuscitation (ECPR) market.

Based on Component, the global Extracorporeal Membrane Oxygenation Machine market is segmented into Pumps, Oxygenators, Controllers, Cannula, and Accessories.

Geographical Analysis

North America region holds the largest market share in the global extracorporeal membrane oxygenation machine market

North America is expected to account for the largest share of the global market in 2022, followed by Europe, Asia-Pacific, and the Rest of the World. The large share of North America is due to the well-developed primary, secondary, and tertiary care hospitals, reimbursement framework, favourable government funding, and higher awareness about the ECMO systems facilitating their adoption in hospitals.

On the other hand, Asia Pacific is expected to be the fastest-growing regional market over the forecast period. This can be attributed to the increasing prevalence of lung cancer in countries, such as China and India. According to National Cancer Centre (NCC), each year ~781,000 patients are diagnosed with lung cancer in China and is one of the leading causes of cancer deaths in the country.

Competitive Landscape

Some of the major manufacturers in the extracorporeal membrane oxygenation machine market are MAQUET Holding B. V. & Co. KG, Medtronic plc, LivaNova PLC. These companies together contributed XX% of the global market in 2019. The other players of the market are XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc, ALung Technologies Inc, and EUROSETS S.r.l.

The key players are adopting various growth strategies such as new product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the Extracorporeal Membrane Oxygenation Machine market globally. For instance,

• Terumo Cardiovascular Systems Corporation has made refinements in existing technology while manufacturing CAPIOX FX Oxygenator.
• Medtronic Plc designed Minimax Plus Oxygen System with functions such as venous aerosols and low arterial ports, integrated into the system to enhance security and performance for patients (neonates and children).

Key Companies to Watch

Medtronic plc

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio:

NAUTILUS ECMO OXYGENATOR: This ECMO Oxygenator has a path of flowing that is transverse with circular profile. Transverse flow reduces the surface contact area as well as achieve lower blood side pressure drop. It is circular that removes the low flow and stasis that occur in corners.

Key Developments: In March 2020, Medtronic showed its portable ventilator design specifications, to speed up the global ventilator production.

The global extracorporeal membrane oxygenation machine market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The Increasing prevalence rates of lung cancer and increasing geriatric population
  • 4.1.2. Restraints:
    • 4.1.2.1. High Cost and adverse effects associated with some extracorporeal membrane oxygenation machine
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1 Porter's Five Forces Analysis
• 5.2 Regulatory Analysis
• 5.3 Supply Chain Analysis
• 5.4 Pricing Analysis
• 5.5 Unmet Needs
• 5.6 Product innovations

6. By Modality Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type Segment
  • 6.1.2. Market Attractiveness Index, By Modality Type Segment
• 6.2. Veno-arterial (VA)
  • 6.2.1.1. Introduction
  • 6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 6.3. Veno-venous (VV)
• 6.4. Arterio-venous (AV)

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 7.1.2. Market Attractiveness Index, By Application Segment
• 7.2. Respiratory
  • 7.2.1.1. Introduction
  • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Cardiac
• 7.4. Extracorporeal Cardiopulmonary Resuscitation (ECPR)

8. By Component

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component Segment
  • 8.1.2. Market Attractiveness Index, By Component Segment
• 8.2. Pumps
  • 8.2.1.1. Introduction
  • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Oxygenators
• 8.4. Controllers
• 8.5. Cannula
• 8.6. Accessories

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
  • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
  • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
  • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
  • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
  • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
  • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. Australia
    • 9.5.6.5. Rest of Asia Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component

10. Competitive Landscape

• 10.1. Key Developments and Strategies
• 10.2. Company Share Analysis
• 10.3. Products Benchmarking
• 10.4. List of Key Companies to Watch

11. Company Profiles

• 11.1. Medtronic plc.

a. Company Overview

b. Product Portfolio and Description

c. Key Highlights

d. Financial Overview

• 11.2. MAQUET Holding B. V. & Co. KG
• 11.3. LivaNova PLC
• 11.4. XENIOS AG
• 11.5. Terumo Corporation
• 11.6. MicroPort Scientific Corporation
• 11.7. NIPRO Corporation
• 11.8. OriGen Biomedical Inc
• 11.9. ALung Technologies Inc
• 11.10 EUROSETS S.r.l.

LIST NOT EXHAUSTIVE

12. Global Extracorporeal Membrane Oxygenation Machine Market - DataM

• 12.1. Appendix
• 12.2. About Us and Component
• 12.3. Contact Us